Chronic pancreatitis (CP) has a profound independent effect on quality of life (QOL). Our aim was to identify factors that impact the QOL in CP patients.
INTRODUCTION
Chronic pancreatitis (CP), a chronic infl ammatory disorder of the pancreas, is characterized by irreversible morphological changes of the pancreas, abdominal pain-which is oft en chronic and debilitating, episode(s) of acute pancreatitis (AP), impairment of endocrine and exocrine function, and Quality of Life in Chronic Pancreatitis is Determined by Constant Pain, Disability/Unemployment, Current Smoking, and Associated Co-Morbidities in a small subset of patients, development of pancreatic cancer ( 1 ) .
In previous single-center studies, quality of life (QOL) in patients with CP was noted to be signifi cantly impaired when compared with historical population controls ( 2, 3 ) . In a large, multicenter study, we demonstrated a profound eff ect of CP on physical and a modest eff ect on mental QOL when compared with subjects without pancreatitis, independent of demographics, risk factors, etiology, and common medical conditions ( 4 ) . Although these data document the poor QOL in CP patients, they do not provide an explanation for the factors responsible for this observation. Understanding these factors is of importance in the clinical management of patients, especially if they can be modifi ed by behavioral changes, treatment of disease, or its complications.
Studies evaluating independent factors associated with low QOL in CP patients have consistently reported abdominal pain to be an important predictor ( 3, (5) (6) (7) (8) (9) (10) . Treatment of pain by surgical or endoscopic therapy has documented eff ect not only in achieving pain relief but also in improving QOL (11) (12) (13) (14) . Etiology of CP has not been found to aff ect QOL ( 3, 5, 8 ) . Younger age, female sex, smoking, alcohol consumption, low body mass index, diabetes, exocrine pancreatic insuffi ciency, pancreatic morphology, and disease duration lower QOL, but their association has been inconsistent across studies ( 3, 5, 7, 8, 10 ) . Th e reasons for this inconsistency include variability in the instruments used to determine QOL, small sample size of studies, and the lack of use of uniform predictor variables. Th e eff ect of pain-related disability or unemployment on QOL has not been adequately studied.
Th e North American Pancreatitis Study 2 (NAPS2) studies have prospectively ascertained over 1,000 well-phenotyped patients with CP from several US centers. Systematically collected data on QOL and several potential predictor variables provided us with an opportunity to determine which factors may aff ect QOL in this cohort.
METHODS

Study population
We utilized data from the NAPS2 studies for this analysis. NAPS2 consists of a series of three studies (original NAPS2, NAPS2-CV, and NAPS2-AS) from 27 centers in the United States that prospectively ascertained 1,195 CP, 569 recurrent AP and 1,109 controls from 2000 to 2014. One of the participating centers only enrolled control subjects. Detailed methodology for the NAPS2 studies has been published (15) (16) (17) . CP was defi ned by defi nitive changes on imaging studies (primarily endoscopic retrograde cholangiopancreatography or computed tomography scan or equivalent changes on magnetic resonance cholangiopancreatography or endoscopic ultrasound) or histology. Th e study was approved by the Institutional Review Board of each center and all subjects provided written informed consent prior to enrollment.
Th e present study includes 1,024/1,195 (85.6%) CP patients from the three NAPS2 studies who provided complete responses for determination of QOL, disability/unemployment, and pain characteristics (pain pattern and severity).
Data collection
Study subjects completed a detailed questionnaire, including information on demographics, family and personal history, exposure to smoking and alcohol, pain experience, disability/ unemployment related to pain from pancreatitis, and QOL. Selfreported alcohol use during the maximum drinking period of life was used to create drinking categories (abstainers: no alcohol use or <20 drinks in a lifetime; light drinkers: ≤3 drinks per week; moderate drinkers: 4-7 drinks per week for females and 4-14 drinks per week for males; heavy drinkers: 8-34 drinks per week for females and 15-34 drinks per week for males; very heavy drinkers: ≥35 drinks per week for both sexes) and smoking (status: never, past, current; amount: <1 packs per day or ≥1 packs per day; and <12, 12-35, and ≥35 pack-years) as described previously ( 15 ) .
Th e enrolling physician investigator completed a separate questionnaire consisting of information on etiology, TIGAR-O ((i) Toxic-metabolic (ii) Idiopathic (iii) Genetic (iv) Autoimmune (v) Recurrent and severe AP or (vi) obstructive) risk factors, phenotypic characteristics (history of AP, age at AP, age at the onset of CP symptoms, age at CP diagnosis, presence of diabetes, exocrine insuffi ciency, imaging features), and treatments received (medications, surgical and endoscopic interventions), and their perceived eff ectiveness.
QOL evaluation
Th e Short Form-12 (SF-12) version 2 was used to assess QOL in the NAPS2-CV and NAPS2-AS studies. In the original NAPS2 study, QOL was assessed using the SF-12 version 1, and scores were transformed to version 2 for interpretation ( 18 ) . SF-12 is a multipurpose generic QOL questionnaire that was derived from the SF-36 Health Survey ( 18, 19 ) . Th e SF-36 and SF-12 have been validated in several languages and disease conditions, including CP ( 2, 3, 20 ) . Th e SF-12 is comprised of 12 questions that measure 8 domains (role physical, role emotional, physical function, social function, mental health, vitality, bodily pain, and general health) and can be summarized into the physical component summary (PCS) and mental component summary (MCS) scores. SF-12 questionnaire takes approximately 2 min to complete without a signifi cant loss of information and is based on a standard recall of 4 weeks ( 18 ) . Th e summary scores for each domain are then transformed to z -scores using the SF-12 scale means and s.d. from the 1998 general US population to produce a normally distributed population score. PCS and MCS scores range from 0 to 100 with a score of 50±10 representing the mean±s.d. for the general population. Th ese scores provide a direct comparison of the distribution in the population of interest when compared with the general population and between groups. A diff erence of three points in the PSC or MCS scores between groups has been suggested to be clinically relevant ( 4 ) .
Pain and disability/unemployment assessment
We used patient-reported pain experience for all comparisons in this study. In the NAPS2-CV and NAPS2-AS studies, there was a leading question on the presence of pain (i.e., Have you
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experienced abdominal pain related to pancreatitis in the past year?). Patients who reported "yes" were asked to choose from one of the fi ve predefi ned pain patterns (episodes of mild-tomoderate pain; constant mild-to-moderate pain; usually pain free with episodes of severe pain; constant mild pain plus episodes of severe pain; and constant severe pain that does not change). For this study, we incorporated the presence, severity, and temporal nature of pain to classify patients into the following fi ve categories: (i) No pain; (ii) Intermittent mild-to-moderate episodes of pain; (iii) Intermittent severe episodes of pain; (iv) Constant mild-to-moderate pain; and (v) Constant mild-to-moderate pain with episodes of severe pain or constant severe pain that does not change. In the original NAPS2 study, a leading question on the presence of pain was not asked and patients were directly asked to complete the question in the fi ve pain patterns ( 15 ) . Th erefore, patients in the original NAPS2 study who did not identify with a pain pattern were excluded from the fi nal analysis ( n =126) as it is impossible to distinguish those patients without pain and those with pain who simply left their pain category blank. In addition, patients from the three NAPS2 studies were asked for the presence of pain-related disability or unemployment.
Statistics
Th e PCS and MCS scores were computed using the scoring method system provided in the SF-12 version 2 reference manual and presented as mean±s.d. ( 18 ) . Descriptive analyses are presented as proportions for categorical data and as mean±s.d. for continuous data. Comparison between the PCS and MCS scores within each group variable was carried out using Kruskal-Wallis test. All variables with a P -value of <0.2 on univariate analysis comparing the PCS and MCS scores were considered for potential inclusion in the multivariable models.
Multivariable linear regression models were used to determine the independent predictors of physical and mental QOL. A backwards selection technique was used to determine significant independent predictors. Age and gender were included in both fi nal models because of clinical signifi cance. Other variables were removed one by one in order of the magnitude of the P -value for the type III F-test, with the exception of diabetes which was removed from the PCS model owing to its small eff ect size compared with the other variables remaining. Models were then re-run until a fi nal model was reached containing only the variables with P <0.05. For the MCS fi nal model, history of liver disease was borderline signifi cant and was included in the fi nal model. Th ere were missing data in some variables, but in no case did they exceed ~6%. Th e PCS model was not examined for interactions to maintain easier interpretation and out of concern of including too many variables in the fi nal model. Signifi cant interactions were examined for the MCS model. For easier interpretation, the fi nal models were centered at the age of 50 years. As the original NAPS2 study used an earlier version of SF12 and the presence of pain was not assessed by a leading question, a sensitivity analysis was performed aft er excluding these patients and using the same variables included in the fi nal models. Data analysis was performed using SAS version 9.4 (SAS Institute Inc., Cary, NC).
RESULTS
Demographics, risk factors, and clinical characteristics
Of the 1,024 CP patients who formed the fi nal study cohort, 381 (37.2%) were enrolled in the original-NAPS2 study, 510 (49.8%) in the NAPS2-CV study, and 133 (13.0%) in the NAPS2-AS study. Th e distribution of baseline socio-demographic and clinical characteristics is shown in Table 1 .
Overall, patients had a mean age of 50.4±14.6 years, 54.6% were male, 74.8% were white, 19.6% were current drinkers, and the majority had a normal/low body mass index (57.6%). Heavy or very heavy drinking during the maximum drinking period of life was reported by 15.1% and 34.9% and past or current smoking by 25.3% and 50.1% patients, respectively. Physicians considered alcohol as the main etiological factor in about half of (50.2%) patients. In >50% patients (54.6%), the duration of CP was ≥4 years.
In our fi nal study cohort, abdominal pain in the year preceding enrollment was present in 91.6%. Th e most common pattern of abdominal pain identifi ed was constant mild-to-moderate pain with episodes of severe pain or constant severe pain (48.5%). Less frequently patients identifi ed intermittent episodes of severe pain (24%), intermittent episodes of mild-to-moderate pain (12.8%), and constant mild-to-moderate pain (6.3%). Pain-related disability/unemployment was reported by 27.1% of patients. About one-third of patients had exocrine insuffi ciency (38.1%) or diabetes (33.1%). Although 40.3% received only medical management, a prior history of pancreatic endotherapy was noted in 37.7% and pancreatic surgery in 21.5% patients. Almost half of the patients (44.3%) had history of gallstones or cholecystectomy. Th e most commonly reported co-morbidities noted were heart disease/heart attack/stroke (11.8%), liver disease (9%), renal disease (6.1%), or prior history of cancer (3.7%).
Predictors of physical QOL
Univariable analysis . Mean PCS score for the study cohort was 36.7±11.7. Univariable analysis for PCS scores based on demographics, risk factors, and clinical characteristics are shown in Table 1 . A signifi cantly lower physical QOL was noted with younger age, female sex, black race, extremes of alcohol consumption, current smoking, disability/unemployment, pain, and diabetes. A medical history of heart disease/heart attack/stroke, cancer, liver disease, renal disease, gallstones, or cholecystectomy was also signifi cantly associated with lower PCS scores. Interestingly, the association was only borderline with disease duration, and no association was noted with body mass index, etiology, exocrine insuffi ciency, pancreatic morphology, prior endotherapy, or pancreatic surgery.
Multivariable analysis .
Results for multivariable regression analyses for physical QOL are shown in Table 2 . Temporal nature and severity of pain had the greatest impact on physical QOL. Compared with patients with no pain, constant mild-to-moderate pain with episodes of severe pain or constant severe pain reduced the PCS score by 10 points, while constant mild-to-moderate pain alone decreased it by 5.2 points. Presence of severe pain that was intermittent was also important but the impact of this (2.6 points) PANCREAS AND BILIARY TRACT VOLUME 112 | APRIL 2017
Machicado et al. of co-morbid conditions also had a signifi cant negative impact-a history of cancer, heart disease/heart attack/stroke, and renal failure reduced the PCS score by 4.4, 3.3, and 2.8 points, respectively. Other factors associated with lower PCS scores on the univariable analysis were not signifi cant aft er adjusting for other variables and were not included in the fi nal regression model. Variables in the fi nal multivariable model explained 27% of the variance in PCS.
To illustrate the impact of individual factors and incremental eff ect of predictive factors, representative PCS score for a 50-yearold man with CP and progressive addition of select attributes are shown in Figure 1 . By adding constant mild-to-moderate pain with episodes of severe pain or constant severe pain, current smoking, and pain-related disability/unemployment, the PCS score would decrease from 45.8 to 27.8.
Predictors of mental QOL
Univariable analysis . Th e mean MCS score for the study cohort was 42.4±12.2. Univariable analysis for MCS scores based on demographics, risk factors, and clinical characteristics is shown in Table 1 . A signifi cantly lower mental QOL was noted with younger age, very heavy drinking, current smoking, disability/ unemployment, and pain. In contrast to physical QOL, mental QOL was signifi cantly lower in patients with physician-defi ned alcohol etiology and the duration of disease. Race, presence of pseudocysts, and exocrine insuffi ciency showed borderline association with MCS score, while sex, body mass index, diabetes, other features on pancreatic morphology, and prior endotherapy or pancreatic surgery showed no association.
Multivariable analysis .
Th e results of multivariable regression analyses for mental QOL are shown in Table 3 . Similar to physical QOL, presence of pain had the most impact on mental QOL. Interestingly, compared with those patients with no pain, a negative impact was seen only for constant pain irrespective of its severity. Th e impact of constant mild-to-moderate pain (6.8 points) was almost similar to constant mild-to-moderate pain with episodes of severe pain or constant severe pain (6.9 points). Intermittent pain irrespective of severity did not signifiwas less than constant pain. Moreover, a history of gallstones or cholecystectomy, which likely refl ects an indirect impact of pain, also had a negative impact (1.6 points). Other disease-related factors with a negative impact included disability/unemployment (5.1 points) and current smoking (2.9 points). Th e eff ect of selfreported drinking history was interesting in that, when compared with lifetime abstainers, the PCS score was signifi cantly higher in patients who reported moderate (4.3 points) or heavy (2.5 points) drinking during their heaviest period of drinking in life. Presence 
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cantly impact MCS score compared with those patients with no pain. Current smoking (3.9 points) and pain-related disability/ unemployment (2.4 points) also signifi cantly reduced the MCS score. An interaction was noted between gender and disability/ unemployment-the eff ect of disability/unemployment on MCS was an additional 3.7 points lower for women than for men. Other factors associated with lower MCS scores on the univariable analysis were not signifi cant aft er adjusting for other variables and were not included in the fi nal regression model. Variables in the fi nal multivariable models explained 17.9% of the variance in MCS score.
To illustrate the impact of individual factors and incremental eff ect of predictive factors, representative MCS score for a 50-yearold CP man are shown in Figure 1 . Progressive addition of select attributes, such as constant mild-to-moderate pain with episodes of severe pain or constant severe pain, current smoking, and disability/unemployment, would decrease the MCS score from 49.8 to 36.6. Sensitivity analysis . Sensitivity analysis aft er excluding patients from the original NAPS2 study showed slight diff erences in the estimated eff ect sizes but were overall consistent with the main analyses (data not shown).
DISCUSSION
In this largest prospective study to date, we found that painespecially constant, pain-related disability/unemployment, current smoking, and concurrent co-morbidities, to have a signifi cant negative impact on the QOL of CP patients. Interestingly, physician-defi ned alcohol etiology, disease duration, pancreatic morphology, and prior endoscopic or surgical treatments did not independently aff ect QOL. Th ese data underscore the need to better understand factors driving pain and to develop eff ective strategies to address them. Facilitating behavioral modifi cation will also have an impact on QOL in these patients. As only a fraction of variance in PCS and MCS scores was explained by our analyses, future studies should focus on identifying other factors aff ecting the QOL of CP patients.
Pain occurs in up to 90% of CP patients, and about half of them have constant pain ( 9 ) . Although the association of pain with poor QOL is consistent across studies ( 3, (5) (6) (7) (8) (9) (10) , whether the eff ect is greater with severity or temporal nature of pain is debatable. A small single-center Polish study of 69 patients revealed that pain intensity correlates with QOL scores more oft en than frequency ( 8 ) . More recently, Olesen et al. ( 10 ) assessed the association between the intensity and temporal pattern of pain with the QOL of 106 CP patients from two tertiary medical centers in the Netherlands and Denmark. In addition to measuring pain severity by the modifi ed brief pain inventory short form ( 21 ), the authors used this scale to indirectly classify pain frequency into three patterns: intermittent, constant, and constant with acute exacerbations. Aft er adjustment for confounders, they found that pain severity but not pain pattern was signifi cantly correlated with global health status, all functional subscales, and most symptom subscales.
In 414 CP patients enrolled in the original NAPS2 study, we reported that constant pain was associated with lower physical and mental QOL scores when compared with those who had intermittent pain ( 9 ) . Th e present study extends those fi ndings using multivariable analyses in a larger cohort and provides a numeric estimate of the eff ect of each pain type on QOL. We found that, compared with those patients with no pain, constant mild-tomoderate pain with episodes of severe pain or constant severe pain to be the strongest predictor of poor physical (10 points reduction) and mental QOL (6.9 points reduction), followed by constant mild-to-moderate pain (5.2 and 6.8 points reduction, respectively). Th e eff ect of constant pain on QOL was statistically signifi cant, clinically relevant, and independent of other covariates such as demographics, risk factors, and co-morbidities. Intermittent severe pain had no eff ect on the mental QOL but had a borderline signifi cant eff ect on physical QOL. Th ese data suggest that both temporal nature and severity of pain are important to consider when designing pain management strategies and clinical management of exocrine insuffi ciency or diabetes, etc. on QOL. We did not fi nd a signifi cant diff erence in QOL based on whether a patient had prior pancreatic endotherapy or surgery. Th is observation merely represents a cross-sectional assessment and does not address the question of whether performance of endotherapy or surgery improves QOL. Such a question can best be answered by studies specifi cally designed to evaluate changes in QOL before and aft er an intervention-in fact, several such studies have concluded the benefi t of these interventions on QOL (11) (12) (13) (14) . A previous study of 83 CP patients (87% alcoholic) found the QOL to be stable over a 2-year period ( 41 )-however, larger studies in patients with diverse etiologies with a longer follow-up period are needed to better assess temporal trends and determinants of QOL. Second, we excluded 126 patients in the original NAPS2 study who did not identify a pain pattern, and given the large sample size in the fi nal cohort, we feel the impact of excluding these patients is likely small and would not aff ect the conclusions. Th ird, recruitment of patients mainly from referral centers and under-representation of racial groups (e.g., Hispanics, Asians, etc.) despite the multicenter eff ort may limit the generalizability of our fi ndings.
Finally, even aft er an exhaustive evaluation of multiple factors, we only explain 27% variance in physical and 17.9% variance in mental QOL, leaving several unmeasured variables. Future studies should assess the role of factors not included in our analyses, examples of which include bowel habits (e.g., diarrhea, steatorrhea, opioid-induced constipation), malnutrition (e.g., weight loss, micronutrient defi ciencies, metabolic bone disease), psychological factors (e.g., depression, anxiety, stress, sleep disturbance, substance abuse), social factors (e.g., work absenteeism, fi nancial status, social support), health-care utilization (e.g., frequency and duration of hospitalizations), adherence to medical care, and genetics. Th e impact of behavioral (e.g., smoking or alcohol cessation strategies, relaxation techniques), medical (e.g., narcotics, neuromodulating agents, antidepressants, pancreatic enzyme replacement, micronutrient supplementation), endoscopic (e.g., pancreatic or biliary stenting, endoscopic shock wave lithotripsy, celiac plexus block) and surgical (e.g., drainage and resection techniques, total pancreatectomy and islet auto transplantation) interventions, and physical therapy needs further assessment. Management of CP by an interdisciplinary team with expertise in primary care, behavioral health, gastroenterology, therapeutic endoscopy, pancreatic surgery, endocrinology, and radiology has been recommended. Th e impact of such an approach on QOL should be empirically evaluated.
In summary, this large multicenter study demonstrated that constant pain, pain-related disability/unemployment, current smoking, and concurrent co-morbidities signifi cantly impair the QOL of CP. Th ese data expand our understanding that both temporal nature and severity of pain are important to consider when designing clinical trials in CP. Developing treatment strategies aimed to target modifi able factors may help in improving the QOL of CP patients. Future research is needed to identify factors that were not included in this study. trials in CP patients. Th e relevance of constant nature of symptoms was aptly demonstrated in the classic study of the natural history of alcoholic CP by Ammann et al. , ( 22 ) where the temporal nature of pain was the primary determinant for the need for surgical intervention. Interestingly, constant pain has also been shown to have a signifi cant impact on QOL in many other health conditions (23) (24) (25) .
Th e eff ect of smoking on QOL in CP diff ers between studies. In two Italian studies, current smoking ( 3 ) and the amount and duration of smoking did not aff ect QOL ( 7 ) . In contrast, we previously had shown and this study confi rmed that current smoking had a signifi cant impact on both physical and mental QOL ( 4 ) . Similarly, Han et al. ( 26 ) reported smokers to have a signifi cantly worse physical QOL when compared with nonsmokers. A Polish study found the duration of smoking to be associated with lower physical functioning and insomnia and the amount of smoking with worse fear of future health ( 8 ) . Th e mechanism by which smoking has an eff ect on QOL is unclear. One possible explanation may be the eff ect of smoking on disease-related manifestations such as worsening of morphology (e.g., calcifi cations, exocrine and/or endocrine function)-however, it is interesting to note that morphological or functional derangements by themselves did not impact QOL. Other possible explanations would be indirect, similar to the eff ect of current smoking on general QOL in conditions related or unrelated to smoking (27) (28) (29) (30) (31) . Prevalence of aff ective spectrum disorders in CP patients is high and patients may smoke to relieve anxiety, depression, or stress that is preexisting or develops aft er diagnosis of CP or to cope with the need to abstain from drinking (32) (33) (34) (35) . Smoking cessation by counseling and/or pharmacological measures should be an important component of the management of CP, not only owing to its association with QOL but also for its impact on disease progression ( 36, 37 ) . Although smoking cessation strategies show good results in many conditions, its results in CP can be challenging and fail in the majority of patients ( 26 ) .
Th e independent eff ect of disability/unemployment on QOL has not been adequately studied. We found disability/unemployment related to CP to have a signifi cant negative impact on physical as well as mental QOL. Wehler et al. ( 5 ) reported an independent reduction of PCS score caused by CP-related unemployment or early retirement. Disability/unemployment can lead to heavy psychological burden, fi nancial distress, and disruption in social and family relationships, which can limit the ability to cope with the disease ( 38, 39 ) . Future strategies should focus to prevent work disability and to help disabled patients to get back into the labor force ( 40 ) .
Strengths of our study include a large, well-phenotyped cohort of patients and a comprehensive analysis of multiple relevant variables. Th is approach overcomes important limitations of prior work in this area. Our study also has limitations. First, this was a one-time assessment of QOL in patients with a chronic condition. Th erefore, we are unable to evaluate for temporal changes in QOL, as well as the direct impact of interventions, such as pancreatic endotherapy or surgery, pain management, medical
